Common use of COVID-19 Leave Clause in Contracts

COVID-19 Leave. Effective the date of ratification of this Agreement through December 31, 2022, employees who are fully vaccinated or have a valid medical or religious vaccine exemption who test positive for COVID-19 using a non-rapid, PCR test, will be eligible to use up to 10 days (NTE 80 hours, prorated for part-time employees) of paid COVID-19 Leave in place of an employee’s own leave or leave without pay to recover from COVID-19. An employee is considered fully vaccinated if the employee has received (1) two doses of Pfizer or Moderna COVID-19 vaccines; (2) one dose of Xxxxxxx & Xxxxxxx COVID-19 vaccine; or (3) any required COVID-19 boosters (as applicable). Notwithstanding the non-rapid PCR testing requirement noted above, the State will temporarily relax the non-rapid PCR test requirement and accept the results of rapid tests for the purpose of verifying a COVID infection. The temporary relaxation of the PCR test requirements will apply to leave requests between December 13, 2021 and March 1 2022. The parties acknowledged that DBM may, in its sole discretion, extend this temporary relaxation of the non-rapid PCR testing requirement beyond March 1, 2022. To eligible for COVID-19 Leave, employees must either:

COVID-19 Leave. Effective the date of ratification of this Agreement through December 31, 2022, employees who are fully vaccinated or have a valid medical or religious vaccine exemption who test positive for COVID-19 using a non-rapid, PCR test, will be eligible to use up to 10 days (NTE 80 hours, prorated for part-time employees) of paid COVID-19 Leave in place of an employee’s own leave or leave without pay to recover from COVID-19. An employee is considered fully vaccinated if the employee has received (1) two doses of Pfizer or Moderna COVID-19 vaccines; (2) one dose of Xxxxxxx & Xxxxxxx COVID-19 vaccine; or (3) any required COVID-19 boosters (as applicable). Notwithstanding the non-rapid PCR testing requirement noted above, the State will temporarily relax the non-rapid PCR test requirement and accept the results of rapid tests for the purpose of verifying a COVID infection. The temporary relaxation of the PCR test requirements will apply to leave requests between December 13, 2021 and March 1 1, 2022. The parties acknowledged acknowledge that DBM may, in its sole discretion, extend this temporary relaxation of the non-non- rapid PCR testing requirement beyond March 1, 2022. To eligible for COVID-19 Leave, employees must either: